Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
6.59
-0.10 (-1.49%)
Oct 10, 2025, 3:01 PM EDT - Market open

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $10.00M in the quarter ending June 30, 2025, a decrease of -50.23%. This brings the company's revenue in the last twelve months to $44.13M, down -24.38% year-over-year. In the year 2024, Aquestive Therapeutics had annual revenue of $57.56M with 13.80% growth.

Revenue (ttm)
$44.13M
Revenue Growth
-24.38%
P/S Ratio
14.30
Revenue / Employee
$310,789
Employees
142
Market Cap
797.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202457.56M6.98M13.80%
Dec 31, 202350.58M2.90M6.09%
Dec 31, 202247.68M-3.15M-6.20%
Dec 31, 202150.83M4.98M10.87%
Dec 31, 202045.85M-6.76M-12.85%
Dec 31, 201952.61M-14.82M-21.98%
Dec 31, 201867.43M512.00K0.77%
Dec 31, 201766.92M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings